RYAH Group – Medical Plant and Nutraceutical Intake Industry

Gregory Wagner, CEO of RYAH Group, a publicly listed big data and technology company focused on valuable predictive analysis in the global medical plant intake industry discusses the significance of data in the cannabis industry and why companies leading with data will be golden in the cannabis sector.  While RYAH offers many different IoT products/devices such as smart inhalers, smart-pens and smart-patches that provide accurate and calculated dosing for individual patients according to their conditions, the proprietary IoT devices are agnostic to the type of medicine, delivery method and are a gateway for delivery and analysis of valuable data. RYAH’s proprietary software platform captures rare and complex data that is invaluable for clinics, physicians, and regulators and enable them to make better and more informed decisions for the industry as a whole.  

Gregory Wagner is CEO of Ryah Group, a publicly listed big data and technology company focused on valuable predictive analysis in the global medical plant intake industry. Greg is a 20+ year former financial markets global head and intrapreneur. He has held executive roles in both United States as CEO of ABN AMRO’s broker deal, and in London as Head of Equity Prime Services for the Royal Bank of Scotland where Greg has co-founded and built several startups from the ground up. Greg holds FINRA Series 7, 63, 24, 55 licenses and MBA in Finance from Fordham University. Greg has also received a Certification in innovation and Strategy from Harvard University. He has a demonstrated history of transformation in the fintech / wearables startup, and financial services industry.